Loading ...

hybrid erlotinib hydrochloride/HPMCP HP55 nanoparticles

Based on

1 Articles
2014 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

hydroxypropyl methylcellulose phthalate

HPMCP HP55
Type Biomolecule
Formula
Role binder
2

erlotinib hydrochloride

Type Single Compound
Formula C22H24ClN3O4
Role fillers

Properties

General physical and chemical properties

Property Value Nanomaterial Variant Source
dissolution kinetics in FaSSIF

More information/entries available to subscribers only.

Or, view sample content

Applications

Area Application Nanomaterial Variant Source
drug delivery

More information available to subscribers only.

Or, view sample content

Characterization

Biological effects

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • hydroxypropyl methylcellulose phthalate
  • erlotinib hydrochloride
  1. pcK6YwyoVbScT
  2. dYAUSryAIErASCA2rkEMNYmgdF2tFphifvdgDthr4Sh9
  3. UyRekH7
  4. 5uA5Z
Product

hybrid erlotinib hydrochloride/HPMCP HP55 nanoparticles

Size: not specified

Medium/Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial